Results for trastuzumabom translation from Slovenian to English

trastuzumabom
trastuzumab

docefrez v kombinaciji s trastuzumabom
docetaxel in combination with trastuzumab

doksorubicinom ali trastuzumabom ali kapecitabinom.
combination with doxorubicin, or trastuzumab, or capecitabine.

docetaksel kabi v kombinaciji s trastuzumabom
docetaxel kabi in combination with trastuzumab

zdravilo taxotere v kombinaciji s trastuzumabom
taxotere in combination with trastuzumab

zdravilo docetaksel teva v kombinaciji s trastuzumabom
docetaxel in combination with trastuzumab

kombinaciji z doksorubicinom ali trastuzumabom ali kapecitabinom.
or in combination with doxorubicin, or trastuzumab, or capecitabine.

docetaksel 100 mg/m2 v kombinaciji s trastuzumabom
docetaxel 100 mg/m² in combination with trastuzumab:

51 taxotere 100 mg/ m2 v kombinaciji s trastuzumabom
52 taxotere 100 mg/ m² in combination with trastuzumab

mediano število predhodnih shem s trastuzumabom je bilo tri.
the median number of prior trastuzumab-containing regimens was three.

usmerjenih študij plodnosti s trastuzumabom emtanzinom niso izvedli.
dedicated fertility studies have not been conducted with trastuzumab emtansine.

15 docetaxel winthrop 100 mg/ m2 v kombinaciji s trastuzumabom
15 docetaxel winthrop 100 mg/ m² in combination with trastuzumab

92 bolnikih, ki so prejemale docetaksel v kombinaciji s trastuzumabom.
92 patients treated with docetaxel in combination with trastuzumab.

92 bolnicah, ki so dobivale docetaksel v kombinaciji s trastuzumabom;
92 patients treated with docetaxel in combination with trastuzumab.

s trastuzumabom emtanzinom niso izvedli študij reproduktivne in razvojne toksičnosti.
no reproductive and developmental toxicology studies have been conducted with trastuzumab emtansine.

skupaj s trastuzumabom in karboplatinom (drugim zdravilom proti raku).
together with trastuzumab and carboplatin (another anticancer medicine).

v kliničnih študijah s trastuzumabom emtanzinom so opažali reakcije zaradi ekstravazacije.
reactions secondary to extravasation have been observed in clinical studies with trastuzumab emtansine.

zaviralni učinek lapatiniba na rast so proučevali na s trastuzumabom tretiranih celičnih linijah.
the growth inhibitory effects of lapatinib were evaluated in trastuzumab-conditioned cell lines.

Če se ukine zdravljenje s trastuzumabom, je treba ukiniti tudi zdravljenje z zdravilom perjeta.
if trastuzumab treatment is discontinued, treatment with perjeta should be discontinued.

namenskih študij embrio-fetalnega razvoja s trastuzumabom emtanzinom pri živalih niso izvedli.
dedicated embryo-foetal development studies have not been conducted in animals with trastuzumab emtansine.